APA

Rompoti N., Katsimbri P., Kokkalis G., Boumpas D., Ikonomidis I., Theodoropoulos K., Rigopoulos D. & Papadavid E. (20200406). Real world data from the use of secukinumab in the treatment of moderate-to-severe psoriasis, including scalp and palmoplantar psoriasis: A 104-week clinical study. : Dermatologic therapy.

Chicago

Rompoti Natalia, Katsimbri Pelagia, Kokkalis Georgios, Boumpas Dimitrios, Ikonomidis Ignatios, Theodoropoulos Konstantinos, Rigopoulos Dimitris and Papadavid Evangelia. 20200406. Real world data from the use of secukinumab in the treatment of moderate-to-severe psoriasis, including scalp and palmoplantar psoriasis: A 104-week clinical study. : Dermatologic therapy.

Harvard

Rompoti N., Katsimbri P., Kokkalis G., Boumpas D., Ikonomidis I., Theodoropoulos K., Rigopoulos D. and Papadavid E. (20200406). Real world data from the use of secukinumab in the treatment of moderate-to-severe psoriasis, including scalp and palmoplantar psoriasis: A 104-week clinical study. : Dermatologic therapy.

MLA

Rompoti Natalia, Katsimbri Pelagia, Kokkalis Georgios, Boumpas Dimitrios, Ikonomidis Ignatios, Theodoropoulos Konstantinos, Rigopoulos Dimitris and Papadavid Evangelia. Real world data from the use of secukinumab in the treatment of moderate-to-severe psoriasis, including scalp and palmoplantar psoriasis: A 104-week clinical study. : Dermatologic therapy. 20200406.